Tumor Genomics, Individual Risk Factors, and External Drivers of Health on Health Outcomes for Patients With Meningioma
University of California, San Francisco · with National Cancer Institute (NCI) · NCT07418775
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- Not posted. Ask the study team before screening.
- Who can join
- Ages 18+ · All sexes
- Healthy volunteers
- Accepted
- Study type
- Observational
- Target enrollment
- 3000
- US sites recruiting
- 1
- Study start
- January 16, 2026
- Record last updated
- May 19, 2026
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
Meningiomas are the most common primary brain tumor, and some groups are diagnosed with higher-grade tumors and have clinically worse outcomes. This study investigates social determinants of health and individual risk factors that may be associated with meningioma.
Being studied: Questionnaire; Medical Record Review
Conditions: Meningioma of Brain; Meningioma; Brain Tumor
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
Inclusion Criteria
- Adults ≥18 years of age
- Able to speak and read English
- Diagnosed with a meningioma
Exclusion Criteria
- Active psychiatric issues (suicidality, active psychosis, grave disability, etc.)
- Inability to consent secondary to severe neurologic deficit or psychiatric distress
- Inability to complete survey secondary to severe neurologic deficit or psychiatric distress
Recruiting US locations
University of California San Francisco
San Francisco, CA 94143
Site contact: Zora Arum · 877-827-3222 · zora.arum2@ucsf.edu
Study contacts (from the official record)
- Zora Arum · 877-827-3222 · zora.arum2@ucsf.edu
Similar studies in California
All healthy volunteers studies in California →- RecruitingHealthy volunteersPhase 1Overnight stay mentioned
A Study to Investigate the Relative Bioavailability and Safety of Different Oral Formulations of Elecoglipron in Healthy Participants
AstraZeneca
- Location
- Glendale, CA + 1 other US site
- Eligibility basics
- Ages 18–55
- RecruitingHealthy volunteersPhase 1Overnight stay mentioned
A Phase I Study to Investigate the Pharmacokinetics and Safety of Capivasertib in Participants With Moderate Hepatic Impairment
AstraZeneca
- Location
- Rialto, CA + 1 other US site
- Eligibility basics
- Ages 18–80
- RecruitingHealthy volunteersPhase 1Overnight stay mentioned
A Study to Learn How the Body Processes the Study Medicine PF-07328948 in People With Reduced Kidney Function
Pfizer
- Location
- Lake Forest, CA + 3 other US sites
- Eligibility basics
- Ages 18–80
- RecruitingHealthy volunteersPhase 1Overnight stay mentioned
Phase 1 Study of SBS-147 in Healthy Adults
Sparian Biosciences, Inc
- Location
- Cypress, CA
- Eligibility basics
- Ages 18–55